JPMorgan upgrades Bouygues stock rating to Overweight on Equans outlook

JPMorgan upgraded Bouygues SA to Overweight from Neutral, raising its price target to EUR49.00 from EUR38.00, citing cleared overhangs and a significantly improved outlook for its Equans subsidiary. The bank anticipates Equans to exceed its original 2027 EBIT margin target, potentially reaching 7% mid-term, which could drive 10% annual EPS upgrades and increase the unit's valuation from EUR10.0 billion to EUR13.6 billion. Further upside is expected from potential French market consolidation by year-end.

Analysis

JPMorgan has upgraded Bouygues SA to Overweight from Neutral and raised its price target by over 28% to EUR49.00 from EUR38.00, signaling a significant shift in outlook. The upgrade is underpinned by two key factors: the resolution of prior uncertainties, specifically a rebased guidance and the company's decision not to exercise call options on its Fiber JV, and a substantially improved forecast for its Equans subsidiary. JPMorgan identifies Equans as the primary value driver, projecting its mid-term EBIT margin could reach 7%, a notable increase from the original 2027 target of 5%. This enhanced margin profile is expected to fuel 10% annual EPS upgrades and has led JPMorgan to increase its valuation of Equans from EUR10.0 billion to EUR13.6 billion, with a potential upside scenario exceeding EUR16 billion. A secondary catalyst is the prospect of French market consolidation by year-end, which could unlock further synergies and improve market dynamics for Bouygues.

Key Decisions for Investors

• Given the significant price target increase and multiple catalysts identified by JPMorgan, investors could view this as a strong signal to re-evaluate Bouygues for a long position or increase existing holdings.
• It is critical to monitor the quarterly performance of the Equans subsidiary for evidence that it is on track to achieve the projected 7% EBIT margin, as this is the core driver of the upgraded valuation and earnings per share estimates.
• Investors should watch for any news or reports concerning consolidation in the French market, as progress toward a deal by year-end could serve as an additional, material catalyst for the stock.